TRIP4 and breast cancer: Thus, UFBP1, like UFL1, plays two opposite roles as a tumor suppressor by inhibiting NF-κB signaling and as a tumor promoter by serving as a cofactor of the UFM1-conjugating system for ASC1 in development of breast cancer.